SeekingAlpha · Feb 12, 2026
Baron Opportunity Fund Q4 2025 Shareholder Letter
During the fourth quarter, Baron Opportunity Fund posted a return of 4.63% (Institutional Shares), outperforming the Russell 3000 Growth Index. Read more here.
NASDAQ · BIOIX
Financial Services · Asset Management
$65.65
Down-$0.71 (-1.07%)
Updated Sep 11, 2026, 7:25 AM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
BIOIX does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning BIOIX.
BIOIX research
Company profile and research snapshot.
The fund invests primarily in equity securities in the form of common stock of U.S. high growth businesses of any market capitalization selected for their capital appreciation potential. The Adviser may invest in companies in any sector or industry that the adviser believes will benefit from innovations and advances in technology.
Consensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Feb 12, 2026
During the fourth quarter, Baron Opportunity Fund posted a return of 4.63% (Institutional Shares), outperforming the Russell 3000 Growth Index. Read more here.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BIOIX.
No results
No recent SID articles mention BIOIX.